Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus

NCT00730002 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2015-12-14

No results posted yet for this study

Summary

The purpose of this study is to determine if three functional Magnetic Resonance brain imaging techniques: Magnetic Resonance Spectroscopy(MRS),Magnetic Resonance perfusion, and Diffusion Tensor Imaging(DTI) can detect brain alterations distinctive for neuropsychiatric systemic lupus erythematosus (NPSLE)and systemic lupus erythematosus(SLE).

Conditions

  • Neuropsychiatric Systemic Lupus Erythematosus

Interventions

PROCEDURE

Magnetic Resonance Angiography (MRA)

As part of the Magnetic Resonance(MR) scan, you will need to lie still on a padded MR table inside the MR machine for about 15 minutes at a time while MR studies are being performed on you. The total time for the clinical portion of the MR study is approximately 35-40 minutes and there will be an additional 30 minutes for the research related MR studies. The total time you will spend on the MR table for this research will seldom be more than one hour.

PROCEDURE

Magnetic resonance imaging

MR spectroscopy

PROCEDURE

MRA

MRA of the brain

PROCEDURE

MRA

PROCEDURE

diffusion Imaging

MRA of the Brain

PROCEDURE

perfusion imaging.

MRA of the brain

Sponsors & Collaborators

Principal Investigators

  • Pia Maly Sundgren, MD-PHD · University of Michigan

  • Pia Maly Sundgren, MD, PHD · University of Michigan

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2014-09-30
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00730002 on ClinicalTrials.gov